Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5

被引:45
作者
Denise, Hubert
Poot, Jacqueline
Jimenez, Maribel
Ambit, Audrey
Herrmann, Daland C.
Vermeulen, Arno N.
Coombs, Graham H.
Mottram, Jeremy C. [1 ]
机构
[1] Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Div Infect & Immun, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland
[3] Intervet Int BV, Boxmeer, Netherlands
[4] Inst Salud Carlos III, Serv Parasitol, WHO, Collaborating Ctr Leishmaniasis, Madrid, Spain
[5] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England
来源
BMC MOLECULAR BIOLOGY | 2006年 / 7卷
基金
英国医学研究理事会;
关键词
D O I
10.1186/1471-2199-7-42
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Visceral leishmaniasis caused by members of the Leishmania donovani complex is often fatal in the absence of treatment. Research has been hampered by the lack of good laboratory models and tools for genetic manipulation. In this study, we have characterised a L. infantum line (JPCM5) that was isolated from a naturally infected dog and then cloned. We found that JPCM5 has attributes that make it an excellent laboratory model; different stages of the parasite life cycle can be studied in vitro, it is accessible to genetic manipulation and it has retained its virulence. Furthermore, the L. infantum JPCM5 genome has now been fully sequenced. Results: We have further focused our studies on LiCPA, the L. infantum homologue to L. mexicana cysteine peptidase CPA. LiCPA was found to share a high percentage of amino acid identity with CPA proteins of other Leishmania species. Two independent LiCPA-deficient promastigote clones (Delta Licpa) were generated and their phenotype characterised. In contrast to L. mexicana CPA-deficient mutants, both clones of. Licpa were found to have significantly reduced virulence in vitro and in vivo. Re-expression of just one LiCPA allele (giving Delta Licpa:: CPA) was sufficient to complement the reduced infectivity of both. Licpa mutants for human macrophages, which confirms the importance of LiCPA for L. infantum virulence. In contrast, in vivo experiments did not show any virulence recovery of the re-expressor clone. Delta LicpaC1:: CPA compared with the CPA-deficient mutant. LicpaC1. Conclusion: The data suggest that CPA is not essential for replication of L. infantum promastigotes, but is important for the host-parasite interaction. Further studies will be necessary to elucidate the precise roles that LiCPA plays and why the re-expression of LiCPA in the Delta Licpa mutants complemented the gene deletion phenotype only in in vitro and not in in vivo infection of hamsters.
引用
收藏
页数:13
相关论文
共 48 条
  • [41] Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features
    Pratlong, F
    Rioux, JA
    Marty, P
    Faraut-Gambarelli, F
    Dereure, J
    Lanotte, G
    Dedet, JP
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (09) : 4077 - 4082
  • [42] A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
    Rafati, S
    Salmanian, AH
    Taheri, T
    Vafa, M
    Fasel, N
    [J]. VACCINE, 2001, 19 (25-26) : 3369 - 3375
  • [43] TAXONOMY OF LEISHMANIA - USE OF ISOENZYMES - SUGGESTIONS FOR A NEW CLASSIFICATION
    RIOUX, JA
    LANOTTE, G
    SERRES, E
    PRATLONG, F
    BASTIEN, P
    PERIERES, J
    [J]. ANNALES DE PARASITOLOGIE HUMAINE ET COMPAREE, 1990, 65 (03): : 111 - 125
  • [44] Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents
    Sereno, D
    Lemesre, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 972 - 976
  • [45] NULL MUTANTS FOR THE LMCPA CYSTEINE PROTEINASE GENE IN LEISHMANIA-MEXICANA
    SOUZA, AE
    BATES, PA
    COOMBS, GH
    MOTTRAM, JC
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1994, 63 (02) : 213 - 220
  • [46] CHARACTERIZATION OF A MULTICOPY GENE FOR A MAJOR STAGE-SPECIFIC CYSTEINE PROTEINASE OF LEISHMANIA-MEXICANA
    SOUZA, AE
    WAUGH, S
    COOMBS, GH
    MOTTRAM, JC
    [J]. FEBS LETTERS, 1992, 311 (02) : 124 - 127
  • [47] From genome to vaccines for leishmaniasis:: Screening 100 novel vaccine candidates against murine Leishmania major infection
    Stober, CB
    Lange, UG
    Roberts, MTM
    Gilmartin, B
    Francis, R
    Almeida, R
    Peacock, CS
    McCann, S
    Blackwell, JM
    [J]. VACCINE, 2006, 24 (14) : 2602 - 2616
  • [48] Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection
    Zhang, WW
    Mendez, S
    Ghosh, A
    Myler, P
    Ivens, A
    Clos, J
    Sacks, DL
    Matlashewski, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) : 35508 - 35515